Shares of Precipio Inc (NASDAQ:PRPO) saw strong trading volume on Tuesday . 3,820,923 shares were traded during mid-day trading, an increase of 233% from the previous session’s volume of 1,148,410 shares.The stock last traded at $0.33 and had previously closed at $0.31.
Separately, ValuEngine upgraded Precipio from a “hold” rating to a “buy” rating in a research note on Wednesday, July 4th.
The company has a quick ratio of 0.11, a current ratio of 0.12 and a debt-to-equity ratio of 0.23.
Precipio (NASDAQ:PRPO) last posted its quarterly earnings results on Thursday, August 23rd. The biotechnology company reported ($0.15) earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.93 by ($2.08). The company had revenue of $0.82 million during the quarter. Precipio had a negative net margin of 904.42% and a negative return on equity of 163.27%.
Precipio Company Profile (NASDAQ:PRPO)
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.
Recommended Story: Risk Tolerance
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.